Elevance Health, Inc. - Common Stock (ELV)

CUSIP: 036752103

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Equity / Common Stock
Shares outstanding
225,970,109
Total 13F shares
213,774,296
Share change
-1,932,352
Total reported value
$99,066,091,155
Put/Call ratio
113%
Price per share
$463.54
Number of holders
1,356
Value change
-$693,430,737
Number of buys
574
Number of sells
498

Quarterly Holders Quick Answers

What is CUSIP 036752103?
CUSIP 036752103 identifies ELV - Elevance Health, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ELV - Elevance Health, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
9.6%
21,654,875
$8,072,938,000 30 Sep 2021
13F
VANGUARD GROUP INC
13F
Company
8.4%
18,928,066
$7,056,384,000 30 Sep 2021
13F
STATE STREET CORP
13F
Company
4.7%
10,569,938
$3,940,473,000 30 Sep 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
4.6%
10,479,219
$3,906,655,000 30 Sep 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
4.3%
9,823,426
$3,662,174,000 30 Sep 2021
13F
FMR LLC
13F
Company
2.8%
6,385,531
$2,380,525,000 30 Sep 2021
13F
Capital International Investors
13F
Company
2.3%
5,200,347
$1,939,340,000 30 Sep 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
4,122,937
$1,532,729,000 30 Sep 2021
13F
BAILLIE GIFFORD & CO
13F
Company
1.8%
3,994,663
$1,489,211,000 30 Sep 2021
13F
Sanders Capital, LLC
13F
Company
1.8%
3,977,162
$1,482,686,000 30 Sep 2021
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
1.7%
3,934,780
$1,466,886,000 30 Sep 2021
13F
Artisan Partners Limited Partnership
13F
Company
1.5%
3,386,097
$1,262,337,000 30 Sep 2021
13F
BANK OF AMERICA CORP /DE/
13F
Company
1.4%
3,145,312
$1,172,572,000 30 Sep 2021
13F
Invesco Ltd.
13F
Company
1.3%
2,955,310
$1,101,739,000 30 Sep 2021
13F
NORTHERN TRUST CORP
13F
Company
1.1%
2,550,689
$950,898,000 30 Sep 2021
13F
EAGLE CAPITAL MANAGEMENT LLC
13F
Company
1.1%
2,546,895
$949,482,000 30 Sep 2021
13F
Nuveen Asset Management, LLC
13F
Company
1.1%
2,480,689
$924,799,000 30 Sep 2021
13F
NORGES BANK
13F
Company
1.1%
2,476,740
$923,329,000 30 Sep 2021
13F
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC
13F
Company
1.1%
2,383,428
$888,542,000 30 Sep 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1%
2,305,647
$859,745,000 30 Sep 2021
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.93%
2,104,748
$817,106,000 30 Sep 2021
13F
First Eagle Investment Management, LLC
13F
Company
0.91%
2,046,440
$762,913,000 30 Sep 2021
13F
Bank of New York Mellon Corp
13F
Company
0.89%
2,000,565
$745,809,000 30 Sep 2021
13F
Legal & General Group Plc
13F
Company
0.87%
1,961,211
$731,138,000 30 Sep 2021
13F
EdgePoint Investment Group Inc.
13F
Company
0.83%
1,867,765
$696,303,000 30 Sep 2021
13F
BARROW HANLEY MEWHINNEY & STRAUSS LLC
13F
Company
0.82%
1,842,798
$686,994,000 30 Sep 2021
13F
Ruane, Cunniff & Goldfarb L.P.
13F
Company
0.81%
1,821,413
$679,023,000 30 Sep 2021
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
0.77%
1,732,684
$645,944,592 30 Sep 2021
13F
Orbis Allan Gray Ltd
13F
Company
0.76%
1,718,049
$640,489,000 30 Sep 2021
13F
FRANKLIN RESOURCES INC
13F
Company
0.76%
1,706,247
$636,089,000 30 Sep 2021
13F
JPMORGAN CHASE & CO
13F
Company
0.74%
1,662,785
$619,885,000 30 Sep 2021
13F
MORGAN STANLEY
13F
Company
0.73%
1,649,939
$615,097,000 30 Sep 2021
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.63%
1,433,363
$534,359,000 30 Sep 2021
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.62%
1,402,872
$522,991,000 30 Sep 2021
13F
Newport Trust Company, LLC
13F
Company
0.61%
1,374,979
$512,592,000 30 Sep 2021
13F
Brave Warrior Advisors, LLC
13F
Company
0.61%
1,371,262
$511,206,000 30 Sep 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.58%
1,300,637
$484,877,000 30 Sep 2021
13F
Vulcan Value Partners, LLC
13F
Company
0.52%
1,168,878
$435,757,000 30 Sep 2021
13F
Grantham, Mayo, Van Otterloo & Co. LLC
13F
Company
0.51%
1,141,846
$425,680,000 30 Sep 2021
13F
Amundi
13F
Individual
0.48%
1,088,280
$405,711,000 30 Sep 2021
13F
TPG Group Holdings (SBS) Advisors, Inc.
13F
Company
0.47%
1,067,795
$398,074,000 30 Sep 2021
13F
Allianz Asset Management GmbH
13F
Company
0.45%
1,023,576
$381,588,000 30 Sep 2021
13F
Altshuler Shaham Ltd
13F
Company
0.45%
1,017,626
$381,379,000 30 Sep 2021
13F
Sumitomo Mitsui Trust Group, Inc.
13F
Company
0.43%
980,560
$365,553,000 30 Sep 2021
13F
Swiss National Bank
13F
Company
0.43%
968,032
$360,882,000 30 Sep 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.41%
923,142
$344,147,000 30 Sep 2021
13F
SCHRODER INVESTMENT MANAGEMENT GROUP
13F
Company
0.4%
907,301
$338,243,000 30 Sep 2021
13F
ROYAL BANK OF CANADA
13F
Company
0.4%
901,631
$336,127,000 30 Sep 2021
13F
DEUTSCHE BANK AG\
13F
Company
0.4%
897,544
$334,606,000 30 Sep 2021
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.39%
884,506
$329,744,000 30 Sep 2021
13F

Institutional Holders of Elevance Health, Inc. - Common Stock (ELV) as of Q4 2021

As of 31 Dec 2021, Elevance Health, Inc. - Common Stock (ELV) was held by 1,356 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 213,774,296 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Capital International Investors, BAILLIE GIFFORD & CO, GEODE CAPITAL MANAGEMENT, LLC, and Sanders Capital, LLC. This page lists 1,358 institutional shareholders reporting positions in this security for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders
1,200
Q4 2021 holders
1,356
Holder diff
156
Investor Q3 2021 Shares Q4 2021 Shares Share Diff Share Chg % Q3 2021 Value $ Q4 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.